coronavirus
Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19.
Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.
The firm's stock price has declined almost 98 percent since its initial public offering in 2021, and some investors have expressed doubts about the future direction of the company.
3EO Health At-Home Molecular COVID-19 Test Nabs FDA EUA
The 3EO Health test uses nucleic acid amplification technology to detect SARS-CoV-2 RNA in anterior nasal swab samples.
Top Five Articles on 360Dx Last Week: Dx Companies' Plans for POC Testing; IVDR Rollout; More
Last week, readers were most interested in a story about the hurdles faced by companies bringing routine testing at the point of care.
US Government Invests $600M in COVID-19 Test Manufacturing
The money will go to 12 US-based manufacturers to produce approximately 200 million over-the-counter COVID-19 tests.
Sensible Diagnostics Nabs RADx Award of up to $1M for Respiratory Panel
The company, recently spun off by Curative, will use the money to develop and commercialize a rapid respiratory test for its point-of-care PCR testing platform.